Association of Plasma Biomarkers of Alzheimer Disease With Cognition and Medical Comorbidities in a Biracial Cohort.
Vijay K RamananJonathan Graff-RadfordJeremy SyrjanenDror ShirAlicia Algeciras-SchimnichJohn LucasYuka A MartensMinerva M CarrasquilloGregory S DayNilufer Ertekin-TanerChristian LachnerFloyd B WillisDavid S KnopmanClifford R JackRonald C PetersenPrashanthi VemuriNeill Graff-RadfordMichelle M MielkePublished in: Neurology (2023)
In a biracial, community-based sample of adults, we observed that sex differences, CKD, and vascular risk factors, but not self-reported race, contributed to variation in plasma AD biomarkers. Although some prior studies have reported primary effects of race/ethnicity, our results reinforce the need to account for broad-based medical and social determinants of health (including sex, systemic comorbidities, and other factors) in effectively and equitably deploying plasma AD biomarkers in the general population.